Time and cost involved in measuring access to medicines: the case of Albania

被引：0
|
作者：
E. Petro [1 ]
I. R. Joosse [2 ]
A. C. M. Siebers [2 ]
T. Martopullo [2 ]
R. P. M. Hart [3 ]
A. K. Mantel-Teeuwisse [2 ]
H. A. van den Ham [2 ]
F. Suleman [2 ]
机构：
[1] Local Healthcare Unit,WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS)
[2] Utrecht University,WHO Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice, Discipline of Pharmaceutical Sciences, School of Health Sciences
[3] Lady of Good Counsel University,undefined
[4] University of KwaZulu-Natal,undefined
来源：
BMC Research Notes | / 18卷 / 1期
关键词：
Access to medicines; Cost expenditures; Data collection; Essential medicines; Monitoring tools; Research methodology; Albania;
D O I：
10.1186/s13104-025-07168-5
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] ACCESS TO MEDICINES INDEX: MEASURING HOW WELL COUNTRIES PROVIDE ACCESS TO MEDICINES
    Shankar, R.
    Hickson, S.
    Gorokhovich, L.
    VALUE IN HEALTH, 2013, 16 (07) : A681 - A682
  • [2] THE BASIC HAMPER OF MEDICINES AS STRATEGY TO IMPROVE THE ACCESS AND COST OF MEDICINES IN PANAMA
    Conte, E.
    Gomez, B.
    Barahona, D.
    VALUE IN HEALTH, 2015, 18 (07) : A849 - A850
  • [3] TIME TO ACCESS ORPHAN MEDICINES IN GREECE
    Chantzaras, A.
    Margetis, A.
    Kani, C.
    Koutsiouris, V
    Bacopoulou, F.
    VALUE IN HEALTH, 2023, 26 (12) : S352 - S352
  • [4] How the MDGs gave up on measuring access to medicines
    Gotham, Dzintars
    Onarheim, Kristine H.
    Barber, Melissa J.
    LANCET GLOBAL HEALTH, 2016, 4 (05): : E296 - E297
  • [5] DEREGULATION AND ACCESS TO MEDICINES: THE CASE OF CHINA
    Song, Y.
    VALUE IN HEALTH, 2019, 22 : S299 - S299
  • [6] ARE WE REALLY MEASURING ACCESS? SYSTEMATIC REVIEW OF ACCESS MEASURES TO MEDICINES IN BRAZIL
    Araujo, V. E.
    Izidoro, J. B.
    Guerra-Junior, A. A.
    Dias, C. Z.
    Ascef, B. O.
    Costa, C. M.
    Nascimento, R. C.
    Acurcio, F. A.
    Alvares, J.
    VALUE IN HEALTH, 2015, 18 (03) : A78 - A78
  • [7] RATIONING THE ACCESS TO HIGH COST MEDICINES IN DEVELOPING COUNTRIES
    Diniz, Debora
    DEVELOPING WORLD BIOETHICS, 2009, 9 (02) : II - III
  • [8] The great medicines scandal - Access is not just about cost
    Waning, BJ
    BRITISH MEDICAL JOURNAL, 2006, 333 (7557): : 44 - 44
  • [9] Barriers to access and use of high cost medicines: A review
    Wahlster, Philip
    Scahill, Shane
    Lu, Christine Y.
    Babar, Zaheer-Ud-Din
    HEALTH POLICY AND TECHNOLOGY, 2015, 4 (03) : 191 - 214
  • [10] Access to medicines: cost as an influence on the views and behaviour of patients
    Schafheutle, EI
    Hassell, K
    Noyce, PR
    Weiss, MC
    HEALTH & SOCIAL CARE IN THE COMMUNITY, 2002, 10 (03) : 187 - 195
12345